This weekend, social media exploded with the story of Martin Shkreli, CEO of Turing Pharmaceuticals, which just made the decision to increase the price of a drug from $13.50 a tablet to $750 a tablet—raising the cost for a full course of treatment to $63,000. The unrepentant Shkreli took to ...